Chronic inflammation can lead to insulin resistance in obesity. Increased mRNA expression of inflammatory markers such as toll-like receptor 4 (TLR4) and interleukin 6 (IL6) were reported both in the tissue and the peripheral blood of obese adolescent and correlated with insulin resistance. DNA methylation surrounding TSS region is known to regulate the level of a gene expression. The aim of the study was to investigate the methylation status of TLR4 and IL6 promoter in peripheral blood of obese adolescent and its correlation to insulin resistance. This was a cross sectional study with observational analytic approached. Fifty adolescents with obesity from Yogyakarta Special Region, aged 15-18 years, z-score value >2 SD, no experience of any acute infections within 2 weeks and signed in informed consent, were selected in this study. Subjects with diabetic mellitus, incomplete data and DNA concentration of <20 µg/mL were excluded. DNA samples were extracted from peripheral blood of the subjects. The bisulfite converted DNA was analyzed for methylation level with direct sequencing. Correlation analysis using Spearman test was performed with significance value was set at p<0.05. No methylation in TLR4 promoter was detected in all subjects. The methylation level of IL6 was transformed to categorical variable. Four (8%) subjects with insulin resistance and 2 (4%) without insulin resistance had methylation on a CpG site. Methylation of IL6 was not statisticaly different between insulin resistance and non-resistance adolescent (p=0.635). The significant correlation was not found between methylation level in IL6 promoter with insulin resistance (HOMA-IR) (r=0.051). Cell specific of methylation mechanism, characteristic of subjects and types of samples were suspected causing those results. In conclusion, no correlation between methylation levels of TLR4 promoter and IL6 with insulin resistance in obese adolescent was observed in this study.
INTRODUCTION
Indonesia has been included in top 10 countries with the highest prevalence of obesity in the world. 1 The prevalence of obese adolescent in Indonesia increased from 1.4% in 2007 to 7.3% in 2013. 2 Around 5.7 % adolescents aged 16-18 years is overweight, while 1.6 % is included in the category of obese. 2 Yogyakarta Special Region is a province in Indonesia that has the highest prevalence of adolescent obesity in 2010 and as one of the cities where the prevalence of obese adolescent prevalence above the national average in 2013. 2, 3 Obesity at a young age will give longterm health impacts, for example the tendency of being obese in adulthood, increasing the risk of developing degenerative diseases such as type 2 diabetes mellitus (T2DM), hypertension, ischemia and stroke, until a decline in life expectancy (life expectance). [4] [5] [6] Insulin resistance (IR) is one of major factors which cause T2DM manifestation. The level of IR by homeostatic model assessmentinsulin resistance (HOMA-IR) is known having linear correlation with body mass index (BMI) and fat deposition percentage in adolescent. 7 Inflammation is the most studied pathway to explain individuals with obesity may develop to insulin resistance. This pathway includes inflammatory activation through toll-like receptor 4 (TLR4) and interleukin 6 (IL6). The pro-inflammatory enzymes activated either by of TLR4 or IL6 may interfere insulin signaling transduction by targeting insulin receptor substrate (IRS). [8] [9] [10] of biochemical parameters. The remaining precipitate including buffycoat were stored in 4 o C until used. In this study, 50 obese subjects followed by the data such as fasting glucose blood (mg/dL), insulin level (mg/dL) and HOMA-IR were chosen by random sampling with sex stratification from the previous study. This study was approved by the Medical and Health Research Ethics Committee of the Faculty of Medicine, Universitas Gadjah Mada, Yogyakarta.
Obese adolescent were defined according to Indonesia Basic Health Research (2013) and WHO (2007) as those having z-score of > 2. Insulin resistance were defined as HOMA-IR > 3.2.
17 Fasting blood glucose ≥ 126 mg/ dl was defined as T2DM.
2 Value of HOMA-IR > 3.2 was defined as insulin resistance. Methylation level of each subject was defined as an average of methylation level of all CpG in target region based on chromatogram from sequencing results. Methylation level of each CpG was calculated by Lewin's equations.
18

DNA extraction and bisulfite treatment
Genomic DNA was extracted by DNA genomic Promega Wizard® Genomic DNA Purification Kit. Four hundred nanogram of genomic DNA was used for bisulfite treatment according to the procedure of EZ -methylation Zymo Gold Kit with a total elution volume of 10 mL and stored at -20°C.
Amplification of target region
Region target of IL6 at -290 to +10 was amplified using primer forward AGTTATTAATAAAAGAAAAA-3' and reverse 5'-ACAAAATAAACCTCAA-ACATCTC-3'. While primer for TLR4 amplification were forward 5'-GTTTTTTT-AGTTATTGGTTTGTAGG-3' and reverse 5'-AAACAAACATCATCCTAACATCATC-3' which is targeting region at -94 to +202.
Cycling condition for amplification of IL6
The increase of expressing gene of TLR4 and IL6 has been reported in obese and T2DM. 11, 12 This increase mainly occur in insulin targeting cells such as adipocytes, hepatocytes, and skeletal muscle cells. [13] [14] [15] One of mechanisms which regulate the level of gene expression is DNA methylation. Although the status and level of methylation is specific to each type of cell but the increase of mRNA TLR4 and IL6 has been reported in polymorphnuclear cell of individuals with obesity and positively correlates with insulin resistance. 11, 16 It has been suggested that there is DNA methylation regulation which cause such increase. However, there was no report about the status of promoter methylation of IL6 and TLR4 with IR in obese adolescent's peripheral blood. This study aims to investigate how the level of the status of promoter methylation of IL6 and TLR4 in obese adolescent and its correlation with insulin resistance.
MATERIALS AND METHODS
Subjects
Samples of this study was a part of samples from the study conducted by Huriaty in 2014 (unpublished). In the previous study, 4000 adolescents from 10 senior high schools in Yogyakarta Special Region followed screening tests such as height (cm) and weight (kg) for grouping by nutritional status. Following the exclusion of subjects with the history of T2DM and kidney diseases, as many as 263 adolescents, aged 15-18 years, was not having any infection in 2 weeks (confirmed by questionnaire and medical examination by doctor), and both of parents and adolescents signed the informed consent, enrolled in the present study as subjects. Blood samples were collected following 10-12 fasting overnight in tube containing EDTA. The collected blood were centrifuged to separate its composition. Blood plasma were used for measurement resistance. The data were then grouped based on the status of insulin resistance by gender stratification to analyse the mean difference between groups. 
Direct sequencing
Thirthy microliter of PCR product and 10 µl sent to 1 st base to be sequenced by Sanger method. Sequencing of IL6 used forward primer whereas TLR4 used reverse primer. PCR clean-up and sequencing protocol was done according to daily protocol of 1 st base.
Statistical analysis
Data were presented as mean ± standard deviation (SD) or as median (minimummaximum) depending on the types of data. The mean difference between groups was tested using unpaired t-test. Correlation analysis between methylation of TLR4 and IL6 promoter was performed using Spearman test. The differences between groups were considered statistically significant if a p value < 0.05.
RESULTS
The chracteristics of subject are presented in TABLE 1. Fifty 50 adolescents with obesity consisting of 25 (50%) male and 25 (50%) female from Yogyakarta Special Region were involved in this study. The mean age of subjects was 16.77±0.72 years. Z -score value mean obtained based on the WHO criteria was 3.8±0.97. Median level of fasting blood glucose, insulin and HOMA-IR values, were 84.5 (68.0-13.0), 19.28 (7.08-52.96) and 4.35 (1.7-10.1), respectively. A total of 68 % of the total subjects in this study had insulin Mean difference of age and z-score was performed using unpaired t-test whereas FBG level, insulin level, and HOMA-IR was performed using Mann Whitney test. The age of subjects was similar across groups. Z-score values and FBG level was significantly different within female between the insulin resistance and non-insulin resistance groups (p<0.05) but not in boys. Levels of insulin and HOMA-IR values were significantly higher in insulin resistance group in both female and male (p < 0.001) (TABLE 2).
Amplification of bisulfite coverted DNA
FIGURE 1a and 1b show that the amplification of bisulfite -modified DNA (Bis -DNA) of gene promoter target region of IL6 and TLR4 was successfully performed. It was characterized by an intense single band on 2% agarose gel that is at 300bp for IL6 and 296 bp for TLR4 compared to DNA marker. Sequencing was performed to confirm that the region amplified by the primer was a target region. The nucleotide sequences obtained from sequencing was aligned to compare with DNA sequences from NCBI using Multalin. The results show that the alignment of the amplified region is equal to the target region with nucleotide similarities 90 %.
Direct Bisulfite Sequencing PCR TLR4
DNA conversion was successful (FIGURE 2). It was shown from the sequence that more than 90 % C non-CpG nucleotide turned into a T nucleotide. The electrogram also did not show any background noise that could interfere the calculation of the percentage of methylation per CpG.
The results of TLR4 promoter region -94 to +202 sequencing showed that the entire nucleotide C of predicted CpG changed into nucleotides T except on CpG1. Cytosine of CpG1 (based on reference sequence) was read as guanine in chromatogram. It indicates that the entire targeted CpG in the target region was unmethylated. The percentage of methylation also could not be calculated because no overlapping found between nucleotides C and T in the predicted CpG.
Targeted IL6 promoters in this study were around -290 to +10 nucleotides of TSS that includes 5 CpGs (FIGURE 3). Several overlapping peak between nucleotide C peak and nucleotide T was found in predicted CpG site of IL6 electrogram. Peak ratio between them was calculated using Lewin's equation to get methylation level of each CpG. Only 6 from 50 subjects showed methylation in the promoter IL6 (FIGURE 4) . The level of methylation in IL6 target region obtained in the study were very low, ranging from 0 to 12.91%. The analysis was performed 
DISCUSSION
Our data show that a total of 68 % of the subjects in this study had insulin resistance (TABLE 1) . These data confirm the results of the previous research that reported that more than a half of the population of children and adolescents with obesity have insulin resistance. 20 The median value of insulin levels in this study was 19.28 μIU/mL with the range of insulin levels obtained was between 7.08 to 52.96 μIU/mL (TABLE 1). Although the value limit of normal insulin levels in previous studies showed varying results, insulin levels in the present study were higher than the cutoff range of hyperinsulinemia in adolescents aged 14-19 years which was 18.15 to 23.73 μIU/mL. 21 A study by Rodriguez-Moran et al., 22 used 16 μIU/mL for hyperinsulinemia cut-off category in adolescents. 22 A study of cardiovascular disease in children and adolescents by the American Heart Association (AHA) established that insulin levels by 15-20 μIU/mL as a borderline high of insulin normal levels. 23 A significant difference occurred between the value of HOMA-IR in the insulin resistance group and the non-insulin resistance both group. High value of HOMA-IR in this study was probably to be more influenced by insulin levels rather than FBG. This is supported by the relatively weak results of correlation test between the levels of FBG and HOMA-IR compared to insulin and HOMA-IR (TABLE  4) . Hyperinsulinemia in adolescents has been reported to be a physiological condition which is affected by growth hormone and an increasing body mass during puberty. 24 Insulin secretion will return to normal level by the end of puberty. 25 However, the condition of hyperinsulinemia accompanied by obesity during adolescence may increase the risk of insulin resistance which is known as a major factor related to cardiovascular disease and type 2 diabetes. 23 Low-grade chronic inflammation and imbalance levels of adipokines in obesity conditions may interfere insulin signal transduction which decreases glucose uptake by cells. The decrease of glucose uptake by cell results in increasing pancreas secretion of insulin as an effort to increase glucose uptake in order to keep blood glucose at normal level.
The degree of insulin resistance has been reported to be linear to BMI and body fat percentage. 7 Insulin resistance in obesity is associated with metaflamation or inflammatory response that occurs as a result of excessive nutrients consumption. 26 Free fatty acids, which is reported to be increasing in condition of obesity, are one of inducing factor for inflammatory response through TLR-4.
13,14,27,28
Proinflammatory enzymes such as JNK and IĸKβ which are active in downstream TLR-4 signaling can lead to impaired insulin signaling through phosphorylation at IRS 1 serine residues.
8 Cytokine IL-6, one of the proinflammatory cytokine which is secreted through TLR-4 signals, can also cause the IRS as an adapter protein loses its' function. SOCS3 which is active in IL-6 signal transduction, is able to decrease the phosphorylation of IRS 1 and even increase the ubiquitilation of IRS 1 and subsequently affect the insulin signal transduction.
9,10 These cellular mechanisms not only cause chronic inflammatory conditions continue to occur, but also interfere insulin signaling, and thus the glucose uptake will be impaired. A decrease in glucose uptake will lead to the increase of insulin secretion induction.
Although all subjects were obese, mean difference test results showed that the z-score value affects the incidence of insulin resistance in adolescent girls but not in boys (p <0.05) (TABLE 2). Level of FBG was also significant in girls group only. Insulin resistance in boy adolescent may occur by hormonal effect on the balance of adipokines. Adiponectin level was reported to decrease in obese condition. During puberty in male adolescents, adiponectin levels decrease with increasing testosterone and negatively correlate with HOMA-IR. 29 Promoter methylation levels of TLR4 and IL6 in this study were detected using direct-BSP methods and were analyzed with Lewin's equation. The present study targetted ±300 bp promoter region of the TSS. Differences of distance between the methylated region with the transcription start site (TSS) order is known to be affecting the expression level. Methylation around TSS such as exon one, and downstream promoter significantly showed lower genes expression than methylation on the upstream promoter or intragenic region and last exons. 30 A study about pattern distribution and methylation level has shown that gene with highest expression has lower methylation on region around 500bp from TSS. 31 Target region in this study has transcription factor binding site as predicted by PROMO software. 32 Each transcription factor was reported to have a role in the regulation of the transcription of the gene.
Based on sequencing of TLR4 promoter region around -94 to +202, it was shown that all subjects were not methylated in all predicted CpG. As far as our knowledge, no studies have reported the methylation level of TLR4 on peripheral blood cells adolescents with obesity and its correlation with insulin resistance. Studies on TLR-4 methylation has been performed in intestinal epithelial cells and gingival tissue. A study by Takahashi et al., 33 using cell intestinal epithelial cell line reported that methylation at -69 to +277 serve to maintain homeostasis condition of normal flora in the digestive tract by emphasizing the expression of TLR-4. 33 The different results between our study and theirs may occur because of the characteristic of methylation mechanisms itself which are specific to each cell. 34 Research on TLR4 promoter methylation at CpG -646 and -822 positions in the gingival tissues showed that almost the whole subjects in the regions were not methylated and were not associated with TLR-4 mRNA transcripts. 35 Because all subjects were not methylated in the region target of the TLR4 promoter, it can be concluded that there was no correlation between the degree of methylation in the TLR4 target region with insulin resistance in adolescents with obesity.
Methylation of CpG on the promoter region has been known to affect the effectiveness of transcription initiation complex formation. However, it was reported that methylation can also occur in untranslated regions, exons, the non-coding region, and repetitive sequence although its mechanism to influence the transcription process is not widely known. 36, 37 Therefore it is possible that epigenetic regulation does not occur in the target region but occurs in other regions. Remely et al., 38 reported that the gene TLR4 exon 1 methylation level of intestinal cells found in individuals with obesity is lower than the control group. 38 Methylation in exon 1 of a gene affects the transcriptional silencing occurence more than the promoter methylation in the upstream portion. 30 However, the mechanisms of how gene's body methylation influence the transcription process effectiveness is still unknown. Methylation in gene's body is suspected to play a role in the splicing process. 39 Targeted IL6 promoters in this study are inside -290 to +10 nucleotides of TSS that includes 5 CpGs (FIGURE 3 ). The level of methylation in IL6 target region obtained in the present study are very low, ranging from 0 to 12.91% and only 6 of the 50 subjects showed methylation in IL6 target region (FIGURE 4) Therefore, the data is transformed into categorical form with minimum requirements 1 of CpGs which shows any methylation is categorized as methylated. Fisher test results in TABLE 3 shows that the relative risk of individuals with methylation on IL6 promoter suffering insulin resistance is smaller (RR=0.978) compared with individuals who were methylated (RR=1.023). However, there is no significant difference between the insulin resistance with no insulin resistance groups (TABLE 3) .
There was no statistically significant correlation between the levels of IL6 promoter methylation with other variables such as z-score, GDP, levels of insulin and HOMA-IR value. Zhang et al., 40 study showed similar results which shows no correlation between IL6 promoter methylation with BMI. 40 Different results were reported by Na et al., 41 which significantly had more IL6 promoter hypermethylation in peripheral blood cells of women with obesity than overweight group or normal BMI group. The occuring hypermethylation is suspected as a negative feedback to suppress the IL-6 levels on the condition of obesity. 41 Promoter DNA methylation may influence the transcription process by either directly inhibits the binding of transcription factors to the binding site or together with MBD, histone deacetylase enzyme and histone methyltransferase enzyme causing modifications of histones. The histone modification can cause chromatin structure to become more compact and therefore the transcription factor binding sites become inaccessible and the transcription process may also be disrupted. DNA methylation mechanism will lead to repression of transcription thus decreasing the expression of a gene or vice versa. 42, 43 Methylation around TSS such as exon-1 and downstream promoter (250bp) results in lower gene expression than methylation on upstream promoter, intragenic region or last exon. Nonetheless, Nile et al., 44 showed that methylation on -1099 significantly represses the expression of mRNA of TLR4. 44 This may occur if the methylated CpG is precisely on TFBS and affects binding affinity between transcription factor and TFBS. 45 There are several possibilities of why methylation in the TLR4 promoter target region was not found and methylation in the IL6 target region was in low levels in this study. First, every subject in this study was an individual with obesity. Obesity is known as a condition due to chronic inflammation which is characterized by increased expression of TLR4 and IL6 not only on the insulin target cells, but also on the peripheral blood cells. 11, 12, 28 Thus, low levels of methylation of IL6 in the target region or even the absence of methylation at TLR4 CpG target allegedly is indeed an up-regulation form of TLR-4 and IL-6 on the obesity condition through DNA methylation.
Toll-like receptor 4 in circulation is mainly expressed by monocytes which are known to secrete IL-6 mostly through the activation of TLR-4 in circulation on the obesity condition 46 However, the composition of monocytes is only about 2-8% of total leukocytes in the circulation. 47 The level of obtained methylation is also suspected to be very low considering that this study used a sample buffycoat and not specific mononuclear cells. Other possibilities for improvement of IL6 mRNA and TLR4 were widely reported increases in peripheral blood cells of individuals with obesity are not regulated by other DNA methylation but by other mechanisms such as mRNA stability, the effectiveness of the enhancer and suppressor, polymorphism influences or the existence of miRNA. The weakness of this study is not to measure the mRNA of TLR-4 or IL-6, therefore it is not known whether there is a relationship between the methylation status in the studied region with the produced mRNA transcripts. Besides, this study did not observe the levels of free fatty acids which act as an initiator of inflammation through TLR4.
The characteristics of subjects in this study had been designed to prevent bias in the obtained methylation results by determining short age limit which is 15-18 years old and making gender stratification. Selection of stratification by gender was based on research which showed differences in methylation levels between men and women; not only in the X chromosome, but also in autosomes. [48] [49] [50] The influence of age on methylation occurs in almost all tissues and healthy cells (noncancer) in humans and can be used to predict a person's age in forensic or can be used as a routine examination for predicting the risk of age-related diseases. [51] [52] [53] 
